Corcept Therapeutics

NASDAQ: CORT · Real-Time Price · USD
71.72
-0.28 (-0.39%)
At close: Aug 15, 2025, 3:59 PM
71.75
0.03%
After-hours: Aug 15, 2025, 04:54 PM EDT

Corcept Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
35.15M 20.55M 30.39M 47.21M 35.12M 27.51M 31.36M 31.38M 27.53M 15.88M 16.6M 34.61M 27.41M 22.8M 32.05M 30.47M 26.52M 23.46M
Depreciation & Amortization
469K 462K 460K 499K 257K 120K 630K 169K 823K 740K 747K 752K 668K 802K 797K 771K 756K 743K
Stock-Based Compensation
19.02M 21.83M 16.8M 16.1M 15.21M 13.25M 13.06M 12.88M 11.86M 11.14M 10.52M 10.55M 10.61M 10.76M 10.81M 10.95M 11.07M 10.1M
Other Working Capital
n/a -28M 15.55M 33M -5.32M 2.86M -27.12M 14.13M 16.22M 1.59M 8M -2.65M -9.04M 7.18M 2.14M 1.82M 3.65M -6.09M
Other Non-Cash Items
7.06M -24.01M -1.83M -2.87M 418K 21.21M -3.19M -2.75M -1.68M -1.5M -738K 251K 764K 1.11M 1.29M 1.33M 1.28M 1.19M
Deferred Income Tax
-17.76M -13.71M -3.86M -15.21M -13.96M -7.16M -3.67M -8.86M -10.24M -6.73M -4.47M -8.87M -10.63M -9.94M 2.3M 4.11M 3.3M -5.36M
Change in Working Capital
n/a n/a 17.35M 28.09M 7.28M -7.41M -32.3M 20.1M 13.99M 6.43M 10.72M -3.64M -10.78M 9.72M 2.18M 1.07M 1.42M -4.72M
Operating Cash Flow
43.94M 5.13M 59.3M 73.83M 41.18M 23.76M 5.89M 52.91M 42.29M 25.96M 33.39M 33.65M 18.04M 35.25M 49.43M 48.7M 44.34M 25.42M
Capital Expenditures
-57K -104K -121K -1.64M -416K n/a n/a -37K -102K n/a -31K -351K -19K -12K -65K -159K -119K -126K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a 109.53M 24M n/a 17.21M 4.44M 41.78M n/a n/a n/a n/a n/a
Purchase of Investments
-23.27M -115.14M -144.57M -223.13M -142.73M -77.88M -29.9M -210.03M -88.81M n/a -96.64M -78.85M -86.96M -92.61M n/a -89.54M -95.88M -127.39M
Sales Maturities Of Investments
93.46M 112.08M 80.33M 180.73M 82.95M 68.86M 47M 100.5M 64.82M 207.47M 79.43M 74.41M 45.18M 42.13M 140.54M 63.89M 120.74M 124.23M
Other Investing Acitivies
n/a n/a n/a n/a -59.78M -9.01M 17.1M -109.53M -24M 207.47M -17.21M -4.44M -41.78M -50.48M 140.54M -25.64M 24.86M -3.16M
Investing Cash Flow
70.13M -3.17M -64.36M -44.04M -60.19M -9.01M 17.1M -109.57M -24.1M 207.47M -17.24M -4.79M -41.8M -50.5M 140.47M -25.8M 24.74M -3.28M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-103.02M -27.43M n/a -11.71M -3.48M -476K -145.43M -5.06M -145.43M -1.23M -846K -15.63M -3.31M -1.89M -207.5M -25.77M -29.17M -33.54M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
84K -39.8M -4.56M -21.09M -1.91M -543K 766K 1.14M -1.82M 181K -846K 1.66M -2.76M -506K -2.52M 2.13M 3.14M -16.44M
Financial Cash Flow
-102.93M -39.8M -4.56M -21.09M -2.15M -543K 766K -3.92M -145.75M 181K -61K -13.96M -2.76M -506K -206.97M -23.64M -26.03M -45.95M
Net Cash Flow
12.93M -37.85M -9.62M 8.7M -21.16M 14.2M 23.75M -60.58M -127.56M 233.61M 16.09M 14.9M -26.52M -15.76M -17.07M -742K 43.05M -23.81M
Free Cash Flow
43.88M 5.02M 59.18M 72.19M 40.77M 23.76M 5.89M 52.87M 42.18M 25.96M 33.36M 33.3M 18.02M 35.23M 49.36M 48.55M 44.22M 25.3M